在发现认知障碍和痴呆症之前,期间和之后,正式和非正式的护理使用:基于人口的匹配研究
Sakura Sakakibara1, Abigail Dove1, Jie Guo1
1Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Journal of Alzheimer's disease : JAD
|June 24, 2025
概括
在认知衰退期间,护理需要增加,从轻度认知障碍阶段开始. 正式和非正式的护理都在增加,随着时间的推移,对于痴呆症患者而言,非正式的护理时间显著增加.
科学领域:
- 老年学是指老年学的学科.
- 神经学 神经学
- 公共卫生 公共卫生
背景情况:
- 痴呆症显著增加了医疗保健的利用率,但整个进展过程中的护理模式尚未完全理解.
- 了解痴呆症连续性的正式和非正式护理需求对于有效的医疗保健规划至关重要.
研究的目的:
- 调查认知障碍,无痴呆症 (CIND) 和痴呆症检测之前和之后老年人正式和非正式护理使用的变化.
- 在经历认知衰退的个体中确定与护理使用相关的因素.
主要方法:
- 一项以人口为基础的研究将患有CIND和痴呆症的老年人与认知完整的对照进行了匹配.
- 通过采访评估了护理使用 (正式和非正式),并使用后勤回归和线性混合效应模型分析数据.
- 检查了关键的与护理相关的因素,如年龄,性别,教育,生活状况和并发症.
主要成果:
- 患有CIND的参与者在检测后增加了护理使用 (OR 2.30-2.63).
- 患有痴呆症的个人随着时间的推移逐渐增加了护理需求 (OR 2.01-13.58).
- 无论是CIND还是痴呆症群体,非正式护理时间 (6.3-32.3小时) 都大幅增加.
结论:
- 护理利用,包括正式和非正式的支持,在CIND阶段升级,随着痴呆症的进展而继续上升.
- 在整个痴呆过程中,非正式护理时间显著且持续增加.
- 研究结果强调了与认知障碍相关的复杂护理要求,并强调了协调护理策略的必要性.
相关概念视频
01:30Dementia
182
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
182
01:30Cognitive Development During Adulthood
303
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
303
01:26Alzheimer's Disease: Overview
684
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684
01:29Documentation in Long-Term and Home Healthcare Setting
994
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
994
01:22Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265